RISE Adult Medication Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 267 participants.
Also called NCT01779362
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 267 participants
- Registry
-
NCT01779362
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01779362. Randomized; quadruple masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2019-02 (actual). Results posted on 2023-05-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RISE Adult Medication Study
- Acronym
- RISE Adult
- Condition
- Prediabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Liraglutide
- Intervention (Drug)
- Glargine
- Intervention (Drug)
- Placebo
- Lead sponsor
- RISE Study Group
- Collaborator
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Record details
- Record id
cardio:ct-nct01779362- Content hash
a5ea4ed05c395f791f975b5946b2628e88357e67e9afb8e1902b67907c63d3bb